Ophthalmic viscosurgical devices effect on corneal endothelial cell protection during Phacoemulsification Ophthalmic viscosurgical devices Corneal endothelial cell protection Phacoemulsification
Conditions
Interventions
Cohesive ophthalmic viscosurgical devices used during Phacoemulsification containing 1% sodium hyaluronate.
,Cohesive ophthalmic viscosurgical devices used during Phacoemulsification containing 1.4% s
Active Comparator Device,Active Comparator Device,Active Comparator Device,Experimental Device
Healon,Healon GV,IAL-F,Visiol
Sponsors
Faculty of Medicine Research fund, Chiang Mai University, Chiang Mai Thailand
Eligibility
Sex/Gender
All
Age
45 Years to 90 Years
Inclusion criteria
Inclusion criteria: Patients at Chiang Mai university hospital between September 2019 to February 2021 who were diagnosed with cataracts and need further cataract surgery
Exclusion criteria
Exclusion criteria: Diagnosis of other retinal disease in the study eye Diagnosis of other glaucoma disease in the study eye History of corneal surgery or diseases in the study eye History of prior anterior chamber inflammation in the study eye Prior ocular trauma in the study eye Patients with underlying systemic disease that may cause corneal problem
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Corneal Endothelial Cell Count at 1 day, 1 week, 1 month, 3 month, 6 month and 12 month after phacoemulsification Tomey EM-4000 Endothelium Microscope | — |
Secondary
| Measure | Time frame |
|---|---|
| Intraocular pressure at 1 day, 1 week, 1 month and 3 month after phacoemulsification Goldmann applanation tonometry | — |
Countries
Thailand
Contacts
Public ContactNawat Watanachai
Department of Ophthalmology, Faculty of Medicine, Chiang Mai university
Outcome results
None listed